198
Participants
Start Date
August 24, 2022
Primary Completion Date
October 6, 2023
Study Completion Date
November 27, 2023
MM-120 (LSD D-Tartrate)
A psychoactive substance that mediates effects mainly through an agonist activity in the serotonin 2A receptor (5-HT2A).
Placebo
A substance that is designed to have no therapeutic value.
Sunstone Therapies, Rockville
iResearch Atlanta, Decatur
CNS Healthcare - Orlando, Orlando
Segal Trials, Lauderhill
Lutheran Hospital - Cleveland Clinic, Cleveland
Great Lakes Clinical Trials, Chicago
Uptown Research, Chicago
Preferred Research Partners, Little Rock
University of Texas Health Houston, Houston
BioBehavioral Research of Austin, Austin
Mountain View Clinical Research, Denver
Wholeness Center, Fort Collins
Cedar Clinical Research, Draper
Cedar Clinical Research - Murray, Murray
Pacific Neuroscience Institute, Santa Monica
Kadima Neuropsychiatry Institute, La Jolla
Irvine Center for Clinical Research, Irvine
SISU, Springfield
Adams Clinical, Watertown
Hassman Research Institute, Berlin
GMI - Princeton Medical Institute, Princeton
Woodstock Research Center, Woodstock
Mind Medicine, Inc.
INDUSTRY